Literature DB >> 21339204

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.

Vincent Wai-Sun Wong1, Grace Lai-Hung Wong, Steven Woon-Choy Tsang, Tina Fan, Winnie Chiu-Wing Chu, Jean Woo, Anthony Wing-Hung Chan, Paul Cheung-Lung Choi, Angel Mei-Ling Chim, James Yun-Wong Lau, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung, Henry Lik-Yuen Chan.   

Abstract

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) affects 20-40% of the general adult population. Due to shared risk factors, it is postulated that NAFLD patients have an increased risk of colorectal neoplasm and should be a target group for screening. The aim of this study was to examine the prevalence of colorectal neoplasm in NAFLD patients and the risk of colorectal neoplasm in relation to the severity of NAFLD histology. Design Cross-sectional study.
SETTING: University hospital with case recruitment from the community and clinics. PATIENTS: Subjects aged 40-70 years were recruited for colonoscopic screening from two study cohorts: (1) community subjects; and (2) consecutive patients with biopsy proven NAFLD. In the community cohort, hepatic fat was measured by proton-magnetic resonance spectroscopy. MAIN OUTCOME MEASURES: Prevalence of colorectal adenomas. Advanced colorectal neoplasm was defined as cancer or adenomas with villous architecture or high grade dysplasia.
RESULTS: NAFLD patients (N=199) had a higher prevalence of colorectal adenomas (34.7% vs 21.5%; p=0.043) and advanced neoplasms (18.6% vs 5.5%; p=0.002) than healthy controls (N=181). Thirteen of 29 (45%) NAFLD patients with advanced neoplasms had isolated lesions in the right sided colon. Among patients with biopsy proven NAFLD, patients with non-alcoholic steatohepatitis (N=49) had a higher prevalence of adenomas (51.0% vs 25.6%; p=0.005) and advanced neoplasms (34.7% vs 14.0%; p=0.011) than those with simple steatosis (N=86). After adjusting for demographic and metabolic factors, non-alcoholic steatohepatitis remained associated with adenomas (adjusted OR 4.89, 95% CI 2.04 to 11.70) and advanced neoplasms (OR 5.34, 95% CI 1.92 to 14.84). In contrast, the prevalence of adenomas and advanced neoplasms was similar between patients with simple steatosis and control subjects.
CONCLUSIONS: Non-alcoholic steatohepatitis is associated with a high prevalence of colorectal adenomas and advanced neoplasms. The adenomas are found more commonly in the right sided colon. Colorectal cancer screening is strongly indicated in this high risk group.

Entities:  

Mesh:

Year:  2011        PMID: 21339204     DOI: 10.1136/gut.2011.237974

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  74 in total

1.  Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.

Authors:  Raja R Narayan; Jennifer W Harris; Joanne F Chou; Mithat Gönen; Fei Bao; Jinru Shia; Peter J Allen; Vinod P Balachandran; Jeffrey A Drebin; William R Jarnagin; Nancy E Kemeny; T Peter Kingham; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2019-10-15       Impact factor: 5.344

2.  Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Authors:  Ken Liu; Vincent Wai-Sun Wong; Keith Lau; Sienna Du Liu; Yee-Kit Tse; Terry Cheuk-Fung Yip; Raymond Kwok; Alex Yiu-Wa Chan; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 3.  Current management of non-alcoholic steatohepatitis.

Authors:  Mark D Muthiah; Arun J Sanyal
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 4.  Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.

Authors:  Kara Wegermann; Jeongeun Hyun; Anna Mae Diehl
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 5.  Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

6.  Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden.

Authors:  Somaya Albhaisi; Danny Issa; Naim Alkhouri
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

7.  Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation.

Authors:  Birju D Bhatt; Thresiamma Lukose; Abby B Siegel; Robert S Brown; Elizabeth C Verna
Journal:  J Gastrointest Oncol       Date:  2015-10

8.  Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.

Authors:  Wenjin Ding; Jiangao Fan; Jianjun Qin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

9.  Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.

Authors:  Taeyoung Lee; Kyung Eun Yun; Yoosoo Chang; Seungho Ryu; Dong Il Park; Kyuyong Choi; Yoon Suk Jung
Journal:  Dig Dis Sci       Date:  2015-09-18       Impact factor: 3.199

Review 10.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.